Luminsan, Liliane .

HRN: 15-22-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
CEFUROXIME 1.5GM (VIAL)
09/29/2025
09/30/2025
IV
1.5gm
PTOR
Pre Op Prophylaxis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: